AGNUS CAPITAL LLP's Insider Trades & SAST Disclosures
AGNUS CAPITAL LLP's most recent trade in Solara Active Pharma Sciences Ltd. was a Pledge of 514,635 Equity Shares done at an average price of Rs. 550 . Disclosure was reported to the exchange on Dec. 3, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
AGNUS CAPITAL LLP's has made SAST transactions in Sequent Scientific Ltd. recently where a Pledge of 4,375,000 shares done . Disclosure was reported to the exchange on June 26, 2020.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sequent Scientific | Agnus Capital LLP | Promoter | Pledge | 24 Dec 2024 | 4,375,000 | 5,481,750 | - | - | 23 Jun 2020 23 Jun 2020 |
SAST (Reg31) | - | Release | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Pledge | 24 Dec 2024 | 5,439,365 | 9,856,750 | - | - | 22 Jun 2020 22 Jun 2020 |
SAST (Reg31) | - | Release | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Pledge | 24 Dec 2024 | 5,481,750 | 0 | - | - | 13 Jul 2020 13 Jul 2020 |
SAST (Reg31) | - | Release | |
| Solara Active Pharma | AGNUS CAPITAL LLP | Promoter | Pledge | 24 Dec 2024 | 329,000 | 0 | - | - | 20 Aug 2020 20 Aug 2020 |
SAST (Reg31) | - | Release | |
| Solara Active Pharma | Agnus Capital LLP | Promoter | Pledge | 24 Dec 2024 | 335,000 | 335,000 | - | - | 25 Nov 2021 25 Nov 2021 |
SAST (Reg31) | - | Creation | |
| Solara Active Pharma | Agnus Capital LLP | Promoter | Pledge | 24 Dec 2024 | 514,635 | 849,635 | - | - | 25 Nov 2021 25 Nov 2021 |
SAST (Reg31) | - | Creation | |
| Solara Active Pharma | AGNUS CAPITAL LLP | Promoter Group | Pledge | 03 Dec 2021 | 514,635 | 849,635 (2.36%) | 1.43% | 550 | 283,049,250 | 25 Nov 2021 25 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Solara Active Pharma | AGNUS CAPITAL LLP | Promoter Group | Pledge | 03 Dec 2021 | 335,000 | 849,635 (2.36%) | 0.93% | 550 | 184,250,000 | 25 Nov 2021 25 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Solara Active Pharma | AGNUS CAPITAL LLP (Revised) | Promoter Group | Revoke | 10 Mar 2021 | 329,000 | 849,635 (3.16%) | 0.92% | 10 | 3,290,000 | 20 Aug 2020 20 Aug 2020 |
Insider Trading | Equity Shares | Pledge Released |
| Solara Active Pharma | AGNUS CAPITAL LLP (Revised) | Promoter Group | Pledge | 13 Jan 2021 | 329,000 | 849,635 (3.16%) | 0.92% | 10 | 3,290,000 | 20 Aug 2020 20 Aug 2020 |
Insider Trading | Equity Shares | Pledge Released |
| Strides Pharma | Agnus Capital LLP | Promoter Group | Disposal | 10 Nov 2020 | 20,000 | 0 (0%) | 0.02% | 662 | 13,240,000 | 04 Nov 2020 04 Nov 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 11 Sep 2020 | 25,700,000 | 0 (0%) | 10.35% | 86 | 2,210,200,000 | 08 Sep 2020 08 Sep 2020 |
Insider Trading | Equity Shares | Off Market |
| Solara Active Pharma | AGNUS CAPITAL LLP | Promoter Group | Revoke | 01 Sep 2020 | 329,000 | 849,635 (3.16%) | 1.22% | 10 | 3,290,000 | 28 Aug 2020 28 Aug 2020 |
Insider Trading | Equity Shares | Pledge Released |
| Sequent Scientific | Agnus Capital LLP | None | Acquisition | 29 Aug 2020 | 25,700,000 | - | 10.35% | - | 19 Aug 2020 20 Aug 2020 |
SAST (10(6)) | - | None | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Acquisition | 28 Aug 2020 | 25,700,000 | 25,700,000 (10.35%) | 10.35% | - | 19 Aug 2020 20 Aug 2020 |
SAST (29(1)) | - | Inter-se Transfer | |
| Solara Active Pharma | AGNUS CAPITAL LLP (Revised) | Promoter Group | Invoke | 12 Aug 2020 | 329,000 | 520,635 (1.94%) | 1.22% | 10 | 3,290,000 | 07 May 2020 07 May 2020 |
Insider Trading | Equity Shares | Invocation Of Pledged |
| Sequent Scientific | Agnus Capital LLP | Promoter | Acquisition | 08 Aug 2020 | 25,700,000 | - | 10.35% | - | 13 Aug 2020 13 Aug 2020 |
SAST (10(1)(a)) | - | None | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Acquisition | 04 Aug 2020 | 25,700,000 | - | 10.35% | - | 06 Aug 2020 06 Aug 2020 |
SAST (10(1)(a)) | - | None | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 17 Jul 2020 | 5,481,750 | 0 (0%) | 2.21% | 100 | 548,175,000 | 14 Jul 2020 14 Jul 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 26 Jun 2020 | 9,814,365 | 5,481,750 (2.21%) | 3.95% | 88.4 | 867,441,640 | 23 Jun 2020 24 Jun 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 25 Jun 2020 | 9,814,365 | 5,481,750 (2.21%) | 3.95% | - | 23 Jun 2020 24 Jun 2020 |
SAST (29(2)) | - | Inter-se Transfer | |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 19 Jun 2020 | 4,475,000 | 15,296,115 (6.16%) | 1.80% | 86 | 384,850,000 | 16 Jun 2020 17 Jun 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Sequent Scientific | Agnus Capital LLP | Promoter | Disposal | 03 Jun 2020 | 1,386,445 | 19,771,115 (7.96%) | 0.56% | 86 | 119,234,270 | 01 Jun 2020 01 Jun 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.